Conditioned place preference (CPP) paradigm

Similar documents
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

Tolerance and Dependence

Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives

AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS

Introduction to Tolerance, Physical Dependence and Withdrawal

The Addicted Brain. And what you can do

Overview. Unit 5: How do our choices change our brains?

NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH

substance abuse and addiction are complex phenomena

The latest in addiction medicine: What every nurse needs to know

Drugs, The Brain, and Behavior

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

WHAT HAPPENS TO OUR BRAIN?

NEUROBIOLOGY OF CANNABIS ADDICTION Part I

similar to other psychoactive drugs, drugs of abuse alter the

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where

Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

1. According to recent US national estimates, which of the following substances is associated

DrugFacts: Treatment Approaches for Drug Addiction

Understanding Addiction: The Intersection of Biology and Psychology

Chapter 9: Drug Abuse and Addiction

DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse

Drug Abuse and Addiction

Objectives. Addiction. Some terms. Some terms. Hierarchy of brain function 9/23/2011 PREGNANCY IN WOMEN WITH SUBSTANCE ABUSE: A DOORWAY TO CHANGE

The Neurobiology of Addiction. An Overview

Treatment Approaches for Drug Addiction

a. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes einforcement

The Neuropharmacology of Drugs of Abuse 3

Alcoholism In The Office SCOTT PAIST, III, M. D.

Addiction Neurobiology

Development of pharmacotherapies for drug addiction: a Rosetta Stone approach

RECENT ADVANCES IN ANIMAL MODELS OF DRUG ADDICTION

American Society of Addiction Medicine

SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013

Treatment Approaches for Drug Addiction

THE BRAIN & DRUGS. Nebraska Training on Substance Abuse Prevention

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

OVERVIEW OF MEDICATION ASSISTED TREATMENT

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Hilary J. Little, Ph.D.

Treatment Approaches for Drug Addiction

The Science of Addiction:

CANNABIDIOL AND ADDICTION

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

ANIMATED NEUROSCIENCE

The Cranium Connection

Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

Addicted. The. White lines on a mirror. A needle and spoon. For many users, the sight of

OVERVIEW OF COGNITIVE BEHAVIORAL THERAPY. 1 Overview of Cognitive Behavioral Therapy

Drug Discovery for the Treatment of Addiction. Medicinal Chemistry Strategies

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

Using Drugs to Treat Drug Addiction How it works and why it makes sense

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

Neurobiology and pharmacology of psychostimulants

PRESCRIPTION DRUG ABUSE prevention

Addiction, OCD, & riding a bike: how opiates control your brain

Alcoholism, Drug Addiction, and the Road to Recovery

Managing Chronic Pain in Adults with Substance Use Disorders

Addictions: Why Don t They Just Quit?

Drug addiction. These factors increase the likelihood of your having an addiction to a legal or an illegal drug:

Neurobiology of Reward and Addiction in the Vulnerable Brain. Alan I. Green, M.D. May 1, 2009

Age-related differences in cocaine place conditioning and cocaine-induced dopamine

Update and Review of Medication Assisted Treatments

Advances in Drug Abuse and Addiction Research from NIDA: Implications for Treatment

MAT Counselor Education Course Exam Questions Packet Part 1

Use of Vivitrol for Alcohol and Opioid Addiction

Effect of exercise on aversion to acute opioid withdrawal in mice

Activation neuroimaging studies - GABA receptor function - alcohol cues in alcoholism

Drugs of abuse (including alcohol)

The Future of Treating Alcoholism: Framing the Key Research Questions

Substance Addiction. A Chronic Brain Disease

LESSON 5.7 WORKBOOK Is addiction a chronic disease?

Medication-Assisted Addiction Treatment

PERSPECTIVES. Opiate versus psychostimulant addiction: the differences do matter FOCUS ON ADDICTION

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Naltrexone and Alcoholism Treatment Test

Chapter Fourteen. Emotion, Reward, Aggression, and Stress

The Science of Addiction

Drugs and Teens: Current Facts and Recent Trends. Agenda. Adolescent development

Neurobiology and Treatment of Alcohol Dependence. Nebraska MAT Training September 29, 2011

Co-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

Involvement of the endocannabinoid system in drug addiction

Heroin s descent Stages of losing control, on the street and in the body

Learning Objectives Drugs disrupt the natural action of neurotransmitters at the synapse. Logistics

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Decision-making is a key activity of everyday life. Consequently,

We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones

Drug Addiction: From Mice to Men and Back

Opioid Dependence: A Chronic, Relapsing Brain Disease

Benzodiazepine Overdose and Withdrawal Are Essentially Never Fatal by Zak Fallows CC-BY license, please reuse

OPIOIDS: D E P E N D E N C E & D E T O X I F I C A T I O N

Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Transcription:

Conditioned place preference (CPP) paradigm 성균관약대장춘곤 2010. 09. 07

Drugs of Abuse Dependence ( 의존성 ) Psychological dependence is the compulsion to repeatedly take a drug for personal satisfaction. - craving, drug-seeking behavior - experimental method: conditioned place preference, self- administration Physical dependence is present when withdrawal of the drug produces symptoms and signs that are frequently the opposite of those sought by the user - withdrawal syndrome Tolerance ( 내성 ) Metabolic Tolerance Behavioral Tolerance- compensatory changes for the drug s effects Functional Tolerance- compensatory changes in receptors Reward ( 보상 ) Reinforcement ( 강화 ) Addiction ( 중독 )

Stages of addiction to drugs of abuse Acute Reinforcement / Social Drug-Taking Escalating / Compulsive Use Binge Drinking Genetic variables Environmental factors Stress Conditioning effects Dependence Withdrawal Relapse Protracted Withdrawal Recovery?

Integrative model of brain and behavior of drugs of abuse Drug Reinforcement (Salience Attribution) Reward circuits (ventral tegmental area, nucleus accumbens) Reward circuits (anterior cingulate, prefrontal cortex) Withdrawal ADDICTION Memory (hippocampus) Conditioned response (amygdala) Binging (Loss of Control) Reward circuits (ventral tegmental area, nucleus accumbens) Top-down control (frontal cortex) Craving (Drug Expectation) (cingulate gyrus, prefrontal cortex, orbitofrontal cortex)

Stages of impulse control disorder and compulsive disorder cycles

Introduction 1 The conditioned place preference (CPP) paradigm is a standard preclinical behavioral model used to study the rewarding and aversive effects of drugs. Although a number of different designs and apparatuses are used in this model, the basic characteristics of this task involve the association of a particular environment with drug treatment, followed by the association of a different environment with the absence of the drug (i.e., the drug s vehicle).

Introduction 2 A conditioned place preference (CPP) : The animals spend significantly more time in the drug-paired compartment versus the vehicle-paired compartment. Ex) Drugs of abuse, such as cocaine conditioned place aversion (CPA) : The animals spend significantly more time in the vehicle-paired compartment versus the drug-paired compartment Ex)Drugs elicit aversive effects, such as lithium chloride The behavioral effects of drugs used in the CPP paradigm depend on species, strain, route of administration, time interval of drug administration, dose concentration, and the CPP apparatus used. Many drugs of abuse produce both CPP and CPA, depending on the dose administered.

Introduction 3 Because the CPP paradigm generally provides a reliable indicator for studying the rewarding effects of drugs that require relatively little training compared to self-administration paradigm, the CPP paradigm has been commonly used in conjunction with standard neuroscience techniques to elucidate the subjective effects of drugs

Common Neuroscience Techniques Used in CPP Technique Example References Lesioning - Spyraki C, Fibiger HC, Phillips AG. Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 1982; 253: 195 203. Knockout mice - Marquez P, Baliram R, Kieffer BL, Lutfy K. The mu opioid receptor is involved in buprenorphineinduced locomotor stimulation and conditioned place preference. Neuropharmacology. 2007; 52: 1336 1341. Microdialysis - Duvauchelle CL, Ikegami A, Asami S, Robens J, Kressin K, Castaneda E. Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration. Brain Res. 2000; 862: 49 58. Microinfusion - van der Kooy D, Mucha RF, O Shaughnessy M, Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res. 1982; 243: 107 117. Neurotransmitter depletion - Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci. 2003; 23: 1879 1885. Strain comparisons - Philibin SD, Vann RE, Varvel SA. et al. Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol Biochem Behav. 2005; 80: 87 92.

Research Design and Methodological considerations

CPP Box 1 SPATIAL PLACE PREFERENCE BOX from Panlab Harvard apparatus

CPP Box 2 Standard two- (left) and three-chamber (right) shuttle boxes used to stud conditioned place preference in rodents. From Med-Associates, Inc.,

Conditioned Place Preference (CPP) Paradigm PRE-TESTING PHASE DAY 1 Pre-exposure DAY 2 Pre-test (baseline) (Drug free) CONDITIONING PHASE DAYS 3, 5, 7, 9 Drug injection DAYS 4, 6, 8, 10 Saline injection TESTING PHASE DAY 11 Test (Drug free)

CPP Method 1

CPP Method 2 Date Period Drug Time Remark Day 1 Pre conditioning Nothing 15 min Free assess all boxes Day 2 Pre testing Nothing 15 min Measure the amount of time spent in each chamber (Baseline) Day 3 A group : Drug treat ment 30 min White compartment Day 4 B group: Saline 30 min Black compartment Day 5 B group: Drug treat ment 30 min White compartment Day 6 A group: Saline 30 min Black compartment Conditioning A group: Drug treat Day 7 30 min White compartment ment Day 8 B group: Saline 30 min Black compartment Day 9 B group: Drug treat ment 30 min White compartment Day 10 A group: Saline 30 min Black compartment Measure the amount of

Drug studies using the CPP Paradigm Psychostimulants and opiates reliably produce a CPP - Cocaine, Amphetamine, Nicotine - Morphine, Heroin, Buprenorphine, - CNS depressants Ethanol, diazepam - Cannabinoid receptor agonist delta-9- tetrahydrocannabinal (THC) - Adrenoceptor agonist clonidine. Many of these compounds also produce CPA, depending on the dose administered. -Nicotine produces CPP in rats that are administered doses between 0.4 and 0.8 mg/kg., whereas higher doses are reported to produce CPA. Similar findings have been shown with other drugs, such as morphine and the psychostimulant apomorphine.

In situ hybridization images of NMDAR subunit mrna NR1 NR2A NR2B NR2C

Morphine Conditioned Place Preference 250 Place preference (sec) 200 150 100 50 0 ** # -50 SAL MK 0.1 SAL MK 0.05 MK 0.1 SAL Morphine 5

Cocaine Conditioned Place Preference 300 250 ** Place preference (sec) 200 150 100 50 0 # -50 SAL MK 0.1 SAL MK 0.05 MK 0.1 SAL Cocaine 15

Methamphetamine Conditioned Place Preference Place preference (sec) 300 250 200 150 100 50 0 ** # -50 SAL MK 0.1 SAL MK 0.05 MK 0.1 SAL Methamphetamine 2

Comparison of CPP and Self-Administration

Summary The CPP paradigm is a useful tool for studying the affective properties of drugs, and is routinely used in concert with standard research techniques in neuroscience. Most drugs of abuse elicit a CPP in rats and mice, and the neural substrates of these effects can often be traced to the mesolimbic DA system. Alternative models for assessing the rewarding effects of drugs (e.g., self-administration) do not always produce similar results, and therefore, researchers should be careful when evaluating results based on the behavioral model they are using in their study